Synopsis: Ajanta Pharma, Lloyds Metals, and Emami saw promoter pledges rise in Q3FY26, with pledge levels at 17.29%, 14.42%, and 11.60%, requiring investor monitoring closely now.
Promoter pledge refers to the portion of a promoter’s shareholding that is offered as collateral to raise loans. While it helps fund business needs or personal obligations, a high pledge level increases financial risk for shareholders, as sharp stock price moves can trigger margin calls and sudden selling pressure. Here are the stocks in which promoters pledged their shares in Q3FY26.
Ajanta Pharma is a specialty-focused pharmaceutical company with a strong presence in branded generics across emerging markets. It has built leadership in therapeutic segments such as ophthalmology, cardiology, and dermatology, supported by in-house R&D, regulated market exposure, and a consistent track record of product launches.
With a market capitalization of Rs 33,315 crore, the shares closed at Rs 2,666 per share, decreased around 0.54 percent as compared to the previous closing price. Promoter holding has stayed stable in a narrow range of 66.2–66.3% from Dec 2023 to Dec 2025, reflecting steady promoter confidence and ownership commitment. Such consistency over eight quarters suggests no dilution pressure and indicates long-term alignment with business growth and shareholder interests.
In contrast, promoter pledging has risen from 12.3% in Dec 2023 to 17.29% in Dec 2025. During the last quarter alone, an additional 2.01% of promoter shares were pledged, taking the total pledge to 17.29%, which remains manageable but needs close tracking.
Lloyds Metals and Energy is an integrated iron ore mining and sponge iron producer with operations centered in Maharashtra. The company has gained prominence due to its captive mining assets, improving infrastructure, and strategic focus on cost efficiency, positioning it well amid rising domestic steel demand.
With a market capitalization of Rs 65,609 crore, the shares closed at Rs 1,205 per share, decreased around 1.93 percent as compared to the previous closing price. Promoter holding has remained largely stable in the 63–64% range over the last six quarters, moving from 63.5% in Jul 2024 to 63.7% in Dec 2025. This consistency indicates sustained promoter confidence and limited equity dilution, offering comfort on long-term ownership stability.
Promoter pledging has declined significantly from a peak of 24.5% in Jul 2024 to 14.42% in Dec 2025. However, 1.28% of promoter shares were pledged in the latest quarter, lifting pledge levels from 13.1%, which calls for monitoring despite overall improvement.
Emami Ltd
Emami Ltd is a leading Indian FMCG player with a strong presence in personal care, healthcare, and wellness products. Known for brands like Navratna and BoroPlus, the company combines deep rural reach, brand-led growth, and consistent innovation to drive steady performance across domestic and international markets.
With a market capitalization of Rs 22,004 crore, the shares closed at Rs 504 per share, decreased around 0.28 percent as compared to the previous closing price. Promoter holding has remained unchanged at 54.8% from Dec 2023 to Dec 2025, reflecting strong ownership stability and long-term promoter commitment. Such consistency over eight quarters indicates no dilution concerns and signals confidence in the company’s business fundamentals and future growth prospects.
Promoter pledging, however, shows some fluctuation. After declining from 13.3% in Dec 2023 to a low of 8.2% in Sep 2024, it has risen to 11.60% in Dec 2025. In the latest quarter, promoters pledged an additional 1.62%, which remains moderate but merits monitoring.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
